Skip to main content
Caplight Logo









Sanacor, Inc.

Sanacor, Inc.

Private
Milwaukee, WisconsinHealthcare & Life Scienceshttps://www.sanacor.com/

Last Round

Seed

Jan 9, 2025

Company Overview

Sanacor, Inc. is a biotechnology company that develops mitochondrial-targeted therapies to address mitochondrial dysfunction in cardiometabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

biotechnologydrug discoverysmall-molecule therapymitochondrial dysfunctionFis1 inhibitordiabetic cardiovascular diseasebiotech startuppreclinical researchautomated molecular designdrug developmentchemputationtherapeutic platformAI drug discoverypharma R&Din silico drug design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sanacor, Inc. Comparables

Compare Sanacor, Inc. with similar companies based on industry and business-model similarity.

Sanacor, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MitoRx Therapeutics
84%
Fission Bio
82%
Mito BioPharma
80%

Sanacor, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 9, 2025

Sanacor, Inc. Investors

Notable investors and investment history

Sanacor, Inc. investors
InvestorRounds
Clarevia VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 9, 2025

    Seed round led by Clarevia Ventures.

Sanacor, Inc. Filings

Explore SEC and related filing metadata, where available.

Sanacor, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sanacor, Inc.'s valuation, stock price, and market status.

Is Sanacor, Inc. a public or private company?

Sanacor, Inc. is a private company.

What is the current stock price of Sanacor, Inc.?

Sanacor, Inc. is a private company with no public stock price. Caplight tracks Sanacor, Inc.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Sanacor, Inc. worth (valuation)?

Valuation information for Sanacor, Inc. is not publicly available.

Can I buy Sanacor, Inc. stock?

Sanacor, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sanacor, Inc.'s last funding round?

Sanacor, Inc.'s most recent funding round was Seed on January 9, 2025.

Who are the main investors in Sanacor, Inc.?

Key investors in Sanacor, Inc. include Clarevia Ventures.

Will Sanacor, Inc. IPO soon?

No public IPO plans have been announced for Sanacor, Inc..

How can I track Sanacor, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sanacor, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMilwaukee, Wisconsin
Year Founded2023
Last FundingJan 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?